Drawing for INDOOR

USPTO serial 75118216

INDOOR

Reviewed by CopyMark Law Group

Reg. 2179869Status 800Registered
Filing date
Status date
Registration date
Aug 11, 1998
Examiner
OWCZARSKI, KAREN
Law office
GENERIC WEB UPDATE

What this means

Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.

Status 800: Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection.

Need help with INDOOR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael J. Hertz

Michael J. Hertz Woods Rogers Vandeventer Black PLC10 South Jefferson StreetSuite 1800Roanoke, VA 24011

Goods and services

ClassDescriptionStatusFirst use
001diagnostic assay preparations for scientific or research use; labelled and unlabelled polyclonal and monoclonal antibodies for scientific or research use or for use in the manufacture of allergen detection systems and devices or allergen purification systems; allergen analysis and purification preparations and substances composed of antibodies or allergens for scientific or research use or for use in the manufacture of allergen detection systems and devices or allergen purification systems; assay systems, composed of antibodies, for detection and measurement of allergen concentrations in indoor and outdoor environments, or in dust, air, foods or any other substances; diagnostic assay systems, composed of antibodies, for detection and measurement of allergen concentrations in indoor and outdoor environments, or in dust, air, foods, or any other substances; rapid test devices, composed of antibodies, for detection and measurement of allergen concentrations in indoor and outdoor environments, or in dust, air, foods or any other substances; and allergen detection devices, composed of antibodies, for detection and measurement of allergen concentrations in indoor and outdoor environments, or in dust, air, foods or any other substancesACTIVE—
005diagnostic assay preparations and substances for clinical or medial use; labelled and unlabelled polyclonal and monoclonal antibodies for clinical or medical laboratory use or for environmental analysis for use in the treatment of allergic diseases, including rhinitis, asthma, atopic dermatitis, food allergies and occupational allergies; allergen analysis and purification preparations and substances, composed of antibodies, for use in the treatment of allergic diseases, including rhinitis, asthma, atopic dermatitis, food allergies and occupational allergies; [ pharmaceutical preparations, namely, epitope mapping systems, composed of antibodies, for use in the treatment of allergic diseases, including rhinitis, asthma, atopic dermatitis, food allergies and occupational allergies; pharmaceutical preparations, namely, rapid test devices, composed of antibodies, for detection and measurement of allergen concentrations in indoor and outdoor environments, or in dust, air, foods or any other substances; pharmaceutical preparations, namely, allergen detection devices, composed of antibodies, for detection and measurement of allergen concentrations in indoor and outdoor environments, or in dust, air, foods, or any other substances; ] assay systems, composed of antibodies for detection of antibodies in blood and other body fluids; diagnostic assay systems, composed of antibodies for detection of antibodies in blood and other body fluids; allergen analysis and purification systems, composed of antibodies, for isolation and purification of natural and recombinant allergens for diagnosis and treatment of allergic diseases; epitope mapping systems, composed of antibodies and natural or recombinant allergens, for use in diagnosis and treatment of allergic diseasesACTIVE—
010medical apparatus, namely, assay systems, composed of plastic microtiter plates, nitrocellulose membranes and gel based affinity matrices, for detection of antibodies in blood and other body fluids; medical apparatus, namely, diagnostic assay systems, composed of plastic microtiter plates, nitrocellulose membranes and gel based affinity matrices, for detection of antibodies in blood and other body fluids; [ medical apparatus, namely, allergen analysis and purification systems, composed of plastic microtiter plates, antibody immunoadsorbents prepared using agarose beads, agarose and acrylamide gels, plastic laboratory columns and tubing, for isolation and purification of natural and recombinant allergens for diagnosis and treatment of allergic diseases; ] medical apparatus, namely, allergen sampling and detection systems, composed of plastic dust collection devices with inner nylon membrane filters, plastic microtiter plates, plastic cassettes containing antibody coated nitrocellulose membranes, and nitrocellulose dipsticks for use in diagnosis and treatment of allergic diseasesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 18, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 18, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 18, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 7, 2018NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED—
Jun 7, 2018RNL2REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Jun 7, 201889AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
May 25, 2018EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
May 22, 2018PR89POST REGISTRATION ACTION MAILED - SEC. 8 & 9—
May 8, 2018APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Apr 24, 2018EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Nov 6, 2017PR89POST REGISTRATION ACTION MAILED - SEC. 8 & 9—
Oct 31, 2017APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 24, 2017E89RTEAS SECTION 8 & 9 RECEIVED—
Aug 11, 2017REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Mar 11, 2013ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 11, 2013REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 10, 2008RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
May 10, 200889AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
May 6, 2008PLGLASSIGNED TO PARALEGAL—
Apr 24, 2008E89RTEAS SECTION 8 & 9 RECEIVED—
Aug 10, 2007CFITCASE FILE IN TICRS—
Nov 24, 2003C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Sep 23, 2003815FREGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED—
Feb 20, 2003MAILPAPER RECEIVED—
Aug 11, 1998R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 19, 1998PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 17, 1998NPUBNOTICE OF PUBLICATION—
Mar 9, 1998CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 3, 1998CNEAEXAMINER'S AMENDMENT MAILED—
Feb 2, 1998CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 29, 1997CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 21, 1997CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 22, 1996CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 7, 1996DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance